📰 Meter Walk Test News
Meter Walk Test News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Meter Walk Test. Real-time updates on events, politics, business and more.
January 26, 2024
Tailored hip-based physical therapy yielded superior outcomes vs spine-focused treatment in older patients.
May 25, 2023
New data from the ongoing Open-Label Phase III Extension Study of PXT3003, the PLEO-CMT-FU trial, are consistent with a good safety profile and long-term treatment effect of PXT3003 measured on... | May 25, 2023
May 25, 2023
New data from the ongoing Open-Label Phase III Extension Study of PXT3003, the PLEO-CMT-FU trial, are consistent with a good safety profile and long-term treatment effect of PXT3003 measured on
February 2, 2023
PARIS, France, February 2nd, 2023, 08:30 am CET - Pharnext SA (FR001400BV89 - ALPHA) (the "Company"), an advanced late-clinical stage biopharmaceutical company developing novel therapeutics for neurodegenerative
January 11, 2023
PARIS, France, January 11th, 2023, 8:30 am CET - Pharnext SA (FR001400BV89 - ALPHA) (the "Company"), an advanced late-clinical stage biopharmaceutical company developing novel therapeutics for rare
December 16, 2021
Press release content from Accesswire. The AP news staff was not involved in its creation.
December 16, 2021
Following Phase2b/SARA-INT clinically meaningful results, Biophytis is starting first regulatory activities to advance from Phase 2 to Phase 3 developmentA Type B/End-of-Phase 2 meeting is planned with
October 4, 2021
Sarconeos (BIO101) at the highest dose (350 mg bid) showed a clinically meaningful improvement in the 400-Meter Walk Test (400MWT), the primary endpoint of...